Head to Head Review: Innovative Eyewear (NASDAQ:LUCY) vs. SS Innovations International (NASDAQ:SSII)

SS Innovations International (NASDAQ:SSII) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings for SS Innovations International and Innovative Eyewear, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1	0	0	0	1.00
Innovative Eyewear	1	1	0	0	1.50

SS Innovations International currently has a consensus price target of $7.00, indicating a potential upside of 162.17%. Given SS Innovations International’s higher probable upside, analysts plainly believe SS Innovations International is more favorable than Innovative Eyewear.

Institutional and Insider Ownership

1.0% of Innovative Eyewear shares are held by institutional investors. 1.7% of Innovative Eyewear shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares SS Innovations International and Innovative Eyewear”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49 million	12.59	-$12.13 million	($0.06)	-44.50
Innovative Eyewear	$2.66 million	2.92	-$7.59 million	($1.29)	-0.69

Innovative Eyewear has lower revenue, but higher earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares SS Innovations International and Innovative Eyewear’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Innovative Eyewear	-225.26%	-88.90%	-80.34%

Volatility & Risk

SS Innovations International has a beta of -1.79, suggesting that its share price is 279% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.74, suggesting that its share price is 174% more volatile than the S&P 500.

Summary

SS Innovations International beats Innovative Eyewear on 7 of the 13 factors compared between the two stocks.

About SS Innovations International

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

About Innovative Eyewear

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.